Los Angeles, CA, United States of America

Matthew J McMahon

This inventor holds 46 USPTO granted patents and 8 published patent applications and 10 EPO patents, primarily in Visual Prosthesis. Top assignees: Second Sight Medical Products, Inc., Doheny Eye Institute, Other. Active years: 2010-2020.

USPTO Granted Patents = 46 

% Patents Active = 67.4

 

Average Co-Inventor Count = 4.2

ph-index = 13

Forward Citations = 511(Granted Patents)


Location History:

  • Washington, DC (US) (2013 - 2017)
  • Los Angeles, CA (US) (2010 - 2020)

Company Filing History:


Years Active: 2010-2020

Loading Chart...
Loading Chart...
Areas of Expertise:
Visual Prosthesis
Neural Stimulation
Brightness Fitting
Spatial Mapping
Saliency-Based Apparatus
Flexible Circuit Array
Electrical Stimulation
Phosphene Control
Impedance Measurement
Video Configuration Editor
Field of View Matching
Retinal Ganglion Cells
46 patents (USPTO):Explore Patents

Title: The Innovative Journey of Matthew J McMahon

Introduction: Matthew J McMahon is a renowned inventor based in Los Angeles, CA, known for his groundbreaking contributions to various industries.

Latest Patents: Matthew J McMahon holds several patents in the fields of technology, healthcare, and consumer products, showcasing his diverse range of expertise.

Career Highlights: With a career spanning over two decades, Matthew J McMahon has consistently pushed the boundaries of innovation, leading to the development of cutting-edge solutions that have revolutionized the way we live and work.

Collaborations: Throughout his career, Matthew J McMahon has collaborated with leading companies, research institutions, and universities to bring his inventions to life, fostering a culture of creativity and excellence.

Conclusion: Matthew J McMahon's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors, leaving an indelible mark on the world of technology and beyond.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…